Clorox Company (NYSE:CLX) stock fell Wednesday after the company reported mixed second-quarter fiscal 2026 results.

Details

Adjusted EPS came in at $1.39, which missed the analyst consensus estimate of $1.43.

Sales stood at $1.673 billion, beating the street view of $1.64 billion.

Net sales declined 1% year over year (Y/Y) on a reported and organic basis, driven by lower consumption.

Gross margin fell 60 basis points Y/Y to 43.2%, owing to higher manufacturing and logistics costs.

Segment Performance

Health and Wellness net sales rose 2% Y/Y, driven by a 2-point increase in volume, mainly from additional shipments tied to the final phase of the ERP transition and strong performance in Professional Products.

Also, International net sales rose 7% Y/Y, led by a favorable price mix, positive foreign exchange effects, and higher volume.

However, Household net sales declined 6% Y/Y, with a 3-point ...